← Back to patent-cliff list
CAS 104-53-0
3-Phenylpropionaldehyde
Codes: Enalapril-080
Application context (from source-drug indications)
Cardiac and vascular disordersAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHypertensionAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHyperlipidaemiaAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilHeart diseaseAtorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilEssential hypertensionEnalapril Maleate/Folic AcidHeart failureEnalapril MaleateHypertensionEnalapril MaleateMyocardial infarctionEnalapril MaleateAngina pectorisEnalapril MaleateLeft ventricular dysfunctionEnalapril MaleateSolid tumourEnalapril Maleate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Atorvastatin/Hydrochlorothiazide/Aspirin/Enalapril | Tier C — Watch / trade | - |
| Enalapril Maleate/Folic Acid | Tier C — Watch / trade | - |
| Enalapril Maleate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Atorvastatin/Hydrochlorothiazide/Aspirin/EnalaprilOptimised routesteps: 3total yield: 37.9g(Enalapril-054)
3-Phenylpropionaldehyde→Ethyl 2-oxo-4-phenylbut-3-enoate→2(R)-Hydroxy-4-phenylbutanenitrile→Ethyl (R)-(-)-2-hydroxy-4-phenylbutyrate
3-Phenylpropionaldehyde→Ethyl 2-oxo-4-phenylbut-3-enoate→2(R)-Hydroxy-4-phenylbutanenitrile→Ethyl (R)-(-)-2-hydroxy-4-phenylbutyrate
3-Phenylpropionaldehyde→Ethyl 2-oxo-4-phenylbut-3-enoate→2(R)-Hydroxy-4-phenylbutanenitrile→Ethyl (R)-(-)-2-hydroxy-4-phenylbutyrate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.